Associated Papers
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations.
Murugesan K et al.
Esmo Open, 2022
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Zingg D et al.
Nature, 2022
35948633 (PubMed )
Supplement: 41586_2022_5066_MOESM4_ESM.xlsx › FMI_All_tumours
Structural basis for fibroblast growth factor receptor activation.
Mohammadi M et al.
Cytokine & Growth Factor Reviews, 2005
Select a paper to view details